Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Inventory: 2009-2025

Historic Inventory for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Sep 2025 value amounting to $176.5 million.

  • UNITED THERAPEUTICS's Inventory rose 20.31% to $176.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $176.5 million, marking a year-over-year increase of 20.31%. This contributed to the annual value of $157.9 million for FY2024, which is 41.23% up from last year.
  • Per UNITED THERAPEUTICS's latest filing, its Inventory stood at $176.5 million for Q3 2025, which was up 4.31% from $169.2 million recorded in Q2 2025.
  • UNITED THERAPEUTICS's 5-year Inventory high stood at $176.5 million for Q3 2025, and its period low was $88.2 million during Q1 2022.
  • Its 3-year average for Inventory is $135.8 million, with a median of $136.5 million in 2024.
  • Its Inventory has fluctuated over the past 5 years, first fell by 5.89% in 2022, then spiked by 41.23% in 2024.
  • Quarterly analysis of 5 years shows UNITED THERAPEUTICS's Inventory stood at $93.8 million in 2021, then rose by 8.74% to $102.0 million in 2022, then grew by 9.61% to $111.8 million in 2023, then surged by 41.23% to $157.9 million in 2024, then grew by 20.31% to $176.5 million in 2025.
  • Its Inventory was $176.5 million in Q3 2025, compared to $169.2 million in Q2 2025 and $165.4 million in Q1 2025.